5 Best Managed Healthcare Stocks To Invest In Right Now

At moments like these, the best I can do is pull out my best Keanu Reeves impersonation: Whoah.

Associated Press

The promise of an easy Fed sure has investors excited. The Dow Jones Industrial Average gained 421.28 points, or 2.4%, to 17.778.15 today, while the S&P 500 rose 2.4% to 4,748.40. Every stock in the Dow finished up today, with Microsoft (MSFT) and International Business Machines (IBM) and Goldman Sachs (GS) leading the way. Perhaps more frightening: By my count, just 21 S&P 500 stocks finished in the red today, as Oracle (ORCL) and First Solar (FSLR) led the benchmark higher.

It’s not just today’s gains, though they are impressive. Consider the two days the S&P 500 just had: It gained 4.5%, with the market up at least 2% on both days. The latter hasn’t happened since April 8, 2002–back when I was a 29-year old day trader not having to compete with those high-frequency guys.

Top Dow Dividend Companies To Watch In Right Now: Dr. Reddy's Laboratories Ltd(RDY)

Dr. Reddy?s Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It produces finished dosage forms, active pharmaceutical ingredients and intermediates, and biotechnology products. The company also conducts research in the areas of cancer, diabetes, cardiovascular, inflammation, and bacterial infection. In addition, it involves in the contract manufacture generic prescription and over-the-counter products for branded and generic companies in the United States. The company primarily focuses on therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management. It markets its products in India, the United States, Europe, and the Russian Federation. The company has a co-development and commercialization agreement with Rheoscience A/S for the development and commercialization of Balaglitazone/DRF 2593, a partial PPAR-gamma agonist for the treatment of type 2 diabetes; an agreement with ClinTec Internatio nal for the development of an anti-cancer compound, DRF 1042; collaboration with the National Cancer Institute in Maryland; and an agreement with Argenta Discovery Limited for the joint development and commercialization of a novel approach to the treatment of chronic obstructive pulmonary disease. It also has an agreement with 7TM Pharma for drug discovery collaboration on selected drug targets; and an agreement with GlaxoSmithKline plc to develop and market pharmaceuticals for the treatment of cardiovascular disease, diabetes, oncology, gastroenterology, and pain management. Dr. Reddy?s Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.

Advisors' Opinion:

• [By Seth Jayson]

  Dr. Reddy's Laboratories (NYSE: RDY  ) reported earnings on May 14. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q4), Dr. Reddy's Laboratories beat expectations on revenues and beat expectations on earnings per share.

• [By Monica Gerson]

  Dr. Reddy's Laboratories (NYSE: RDY) is expected to report its Q4 earnings at $0.52 per share.

  YuMe (NYSE: YUME) is estimated to post a Q1 loss at $0.15 per share on revenue of $35.36 million.

• [By Ben Levisohn]

  Teva has dropped 7.7% to $37.85 today at 3:23 p.m. but doesn’t seem to be spreading though the generic drug space. Taro Pharmaceuticals (TARO) ha gained 1.1% to $79, while Actavis (ACT) has gained 1.2% to $156.25 and Dr. Reddy’s Laboratories (RDY) has advanced 1% to $40.24. Mylan (MYL) has dropped 0.7% to $38.40.

5 Best Managed Healthcare Stocks To Invest In Right Now: Watson Pharmaceuticals Inc.(WPI)

Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products in the United States, western Europe, Canada, Australasia, Asia, South America, and South Africa. The company offers its products for therapeutic categories, such as central nervous system, cardiovascular, hormones and synthetic substitutes, anti-infective agents, and urology. It operates in three segments: Global Generics, Global Brands, and Distribution. The Global Generics segment develops, manufactures, and sells generic pharmaceutical products, as well as distributes generic versions of third parties? brand products. This segment offers various dosage forms, such as oral solids, transdermals, injectables, inhalation products, and transmucosals for indications, including pregnancy prevention, pain management, depression, hypertension, and smoking cessation. The Global Brands segment pr omotes and co-promotes Rapaflo, Gelnique, Trelstar, Androderm, Crinone, ella, INFeD, Generess, sodium ferric gluconate, AndroGel, and Femring branded products; and markets its products through sales professionals. It also sells various non-promoted products. The Distribution segment distributes generic and select brand pharmaceutical products, vaccines, injectables, and over-the-counter medicines to independent pharmacies, alternate care providers, pharmacy chains, and physicians? offices. The company sells its generic and brand pharmaceutical products primarily to drug wholesalers, retailers, and distributors, including national retail drug and food store chains, hospitals, clinics, mail order, government agencies, and managed healthcare providers, such as health maintenance organizations and other institutions. Watson Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Parsippany, New Jersey.

Advisors' Opinion:

• [By Holly LaFon] n Pharmaceuticals stock has been on a decidedly upward trajectory in the last five years, increasing 108 percent. It became slightly cheaper in 2011, however. Dalio has been trading the stock for years but most recently he bought 314,360 shares at about $65 per share in the fourth quarter of 2011 after the stock had ventured off of its 52-week high of $73.35 it climbed to in the middle of the year.

  Watson has a long-term record of profitability and growth, with an 11.9% 10-year revenue per share growth rate and 14.2% 10-year free cash flow per share growth rate.

  Though the stock price declined in late 2011, the company in November reported double-digit net revenue and earnings growth. The company also announced that month an exclusive agreement with Pfizer Inc. (PFE) to launch a generic version of Lipitor, the world�� best-selling drug in the history of pharmaceuticals. It also received approval from the FDA to start producing a generic version of the birth control drug Yaz that month, a drug with sales of $173 million in the 12 months ending Sept. 30, 2011.

  In February, Watson announced a full-year 2011 net revenue increase of 29 percent and EPS increase of 39 percent, due in large part to the successful launch of a total of 189 generic products globally for the year. Currently it is using its strong cash position to invest in growth markets, Canada and European operations.

  In spite of the good news and increasing its full-year revenue forecast by $100 million to about $5.4 billion, the stock is up just 0.05 percent year to date.

  Dalio�� next largest purchase was Berkshire Hathaway Inc. (BRK.B), and three new buys: BCE Inc. (BCE), The Goldman Sachs Group Inc. (GS), and Peabody Energy Corp. (BTU).

  Dalio staking over 32 percent of his fund in emerging markets is tantamount to a forecast that emerging markets will outperform from the macro guru. His other top purchases have clear growth prospects. To see more of what Dalio

• [By Louis Navellier]

  Actavis Plc is one of the world’s largest generic drugmakers. For the past three decades, this company was known as Watson Pharmaceuticals (WPI), but the company rebranded itself as Actavis in 2013. With a portfolio of over 190 pharmaceutical product families, Actavis has its name on everything from antibiotics to contraceptives to smoking cessation treatments.

5 Best Managed Healthcare Stocks To Invest In Right Now: Lantrovision(s)

Lantrovision (S) Ltd engages in the design, installation, supply, and provision of consultancy services on network integration and structured cabling. It is involved in the design and installation of computer cabling, as well as the trade of related accessories and peripherals; provision of cabling infrastructure services; sale of cabling accessories; and provision of system integration and network infrastructure services, as well as offers installation, maintenance, and support services for structured cabling systems and components. The company also engages in the structure, design, installation, and consultation of network system with computer communication technology. In addition, it manufactures and sells structuralized cable laying system and multimedia technology; trades in computer peripherals, electronic components, and products for various applications, planners, consultants, advisors, and managers in relation to computer services; and supplies data backup and ret rieval systems. Further, the company provides solutions for testing, monitoring, and analyzing enterprise and telecommunication networks; and contracting services for voice, data, and telecommunication. It primarily operates in Singapore, Malaysia, Hong Kong, China, and Korea, as well as in Thailand and the Philippines. The company was founded in 1990 and is based in Singapore.

Advisors' Opinion:

• [By Bob Chandler]

  Investors seem to be anticipating further consolidation among wireless carriers. Reports suggest Sprint Nextel (NYSE: S  ) may be considering an offer for T-Mobile US (NYSE: TMUS  ) . While a combination between the third and fourth largest U.S. wireless providers might be a good move for those involved, industry giants AT&T (NYSE: T  ) and Verizon Communications (NYSE: VZ  ) may end up being the bigger winners.�

5 Best Managed Healthcare Stocks To Invest In Right Now: Union First Market Bankshares Corp (UBSH)

Union First Market Bankshares Corporation is a bank holding company. The Company offers financial services through its community bank subsidiary Union First Market Bank and three non-bank financial services affiliates. The Company�� non-bank financial services affiliates are Union Mortgage Group, Inc., Union Investment Services, Inc. and Union Insurance Group, LLC. The Company operates in two segments: traditional full service community banking business and its mortgage loan origination business. The Company is a community banking organization based in Virginia and provides full service banking to the Northern, Central, Rappahannock, Shenandoah, Tidewater, and Northern Neck regions of Virginia through Union First Market Bank. Union First Market Bank (the Bank) is a full service community bank offering consumers and businesses a range of banking and related financial services, including checking, savings, certificates of deposit and other depository services, as well as loans for commercial, industrial, residential mortgage and consumer purposes. The Bank issues credit cards and delivers automated teller machine (ATM) services. The Bank also offers Internet banking services and online bill payment for all customers, whether retail or commercial. The Bank also offers private banking and trust services to individuals and corporations through its Financial Guidance Group. In January 2014, the Company acquired StellarOne Corporation.

As of December 31, 2011, Union First Market Bank operated 99 locations in the counties of Albemarle, Caroline, Chesterfield, Essex, Fairfax, Fauquier, Fluvanna, Frederick, Hanover, Henrico, James City, King George, King William, Lancaster, Loudoun, Nelson, Northumberland, Richmond, Spotsylvania, Stafford, Warren, Washington, Westmoreland, York, and the independent cities of Charlottesville, Colonial Heights, Culpeper, Fredericksburg, Harrisonburg, Newport News, Richmond, Staunton, Stephens City, Waynesboro, Williamsburg, and Winchester. Union First Market Bank a! lso operates loan production offices in Staunton, Winchester, and Tappahannock. Union Investment Services, Inc. provides brokerage services; Union Mortgage Group, Inc. provides a line of mortgage products, and Union Insurance Group, LLC offers various lines of insurance products. Union First Market Bank also owns a non-controlling interest in Johnson Mortgage Company, L.L.C.

Union Investment Services, Inc. provides securities, brokerage and investment advisory services. It has 11 offices within the Bank�� trade area and is a full service investment company handling all aspects of wealth management, including stocks, bonds, annuities, mutual funds and financial planning. Securities are offered through a third party contractual arrangement with Raymond James Financial Services, Inc., an independent broker dealer. Union Mortgage Group, Inc., (UMG) has offices in Virginia (seven), Maryland (three), North Carolina (three), and South Carolina (two). UMG is also licensed to do business in selected states throughout the Mid-Atlantic and Southeast, as well as Washington, D.C. It provides a variety of mortgage products to customers in those areas. The mortgage loans originated by UMG are generally sold in the secondary market through purchase agreements with institutional investors. Union Insurance Group, LLC (UIG), an insurance agency, is owned by the Bank and Union Mortgage. This agency operates in a joint venture with Bankers Insurance, LLC, an insurance agency owned by community banks across Virginia and managed by the Virginia Bankers Association. UIG generates revenue through sales of various insurance products, including long term care insurance and business owner policies.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of StellarOne (NASDAQ: STEL  ) , a commercial, mortgage, and wealth management bank servicing small and medium-sized businesses in Virginia, jumped as much as 20% after agreeing to be purchased by Union First Market Bancshares (NASDAQ: UBSH  ) .

• [By GuruFocus]

  Reduced: Union First Market Bankshares Corp (UBSH)

  Tom Gayner reduced to his holdings in Union First Market Bankshares Corp by 12.64%. His sale prices were between $18.24 and $20.59, with an estimated average price of $19.52. The impact to his portfolio due to this sale was -0.18%. Tom Gayner still held 1,658,339 shares as of 06/30/2013.